Highlights NanoRepro AG

Equities

NN6

DE0006577109

Market Closed - Xetra Other stock markets 11:38:29 2024-05-10 EDT			Pre-market 01:48:30
1.82 ^EUR	+0.28%		1.798	-1.21%

2023	NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022.	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-31	CI
NanoRepro AG commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved on April 29, 2022.	23-05-21	CI
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-04	CI
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-27	CI
NanoRepro AG Reports Earnings Results for the Full Year Ended December 31, 2021	22-06-13	CI
NanoRepro to Supply 41 Million Rapid COVID-19 Antigen Tests to Viromed	21-11-24	MT
NanoRepro AG Reports Earnings Results for the Half Year Ended June 30, 2021	21-09-23	CI
NanoRepro : Secures CE Mark on Two SARS-CoV-2 Tests	21-06-14	MT
Nanorepro Ag Reports Earnings Results for the Full Year Ended December 31, 2020	21-05-20	CI
NanoRepro AG Signs Distribution Agreement for Romania, Moldova	15-06-18	CI
NanoRepro AG (DB:NN6) acquired brand alphabiol from Alphablom AG.	15-03-03	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW